Jason E. Stout

9.6k total citations
148 papers, 4.1k citations indexed

About

Jason E. Stout is a scholar working on Epidemiology, Infectious Diseases and Surgery. According to data from OpenAlex, Jason E. Stout has authored 148 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 102 papers in Epidemiology, 94 papers in Infectious Diseases and 33 papers in Surgery. Recurrent topics in Jason E. Stout's work include Tuberculosis Research and Epidemiology (79 papers), Mycobacterium research and diagnosis (53 papers) and Pneumocystis jirovecii pneumonia detection and treatment (26 papers). Jason E. Stout is often cited by papers focused on Tuberculosis Research and Epidemiology (79 papers), Mycobacterium research and diagnosis (53 papers) and Pneumocystis jirovecii pneumonia detection and treatment (26 papers). Jason E. Stout collaborates with scholars based in United States, Canada and Hong Kong. Jason E. Stout's co-authors include Victor L. Yu, Lara Beth Gadkowski, Carol Hamilton, Wing Wai Yew, Won‐Jung Koh, Michele Best, Matthew G. Johnson, David P. Holland, Paul W. Muraca and Gary M. Cox and has published in prestigious journals such as Cell, JAMA and Nature Communications.

In The Last Decade

Jason E. Stout

142 papers receiving 3.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jason E. Stout United States 38 2.1k 2.0k 810 708 639 148 4.1k
Phyllis Della‐Latta United States 46 1.8k 0.9× 2.4k 1.2× 362 0.4× 570 0.8× 606 0.9× 119 5.2k
Sílvia Figueiredo Costa Brazil 41 2.2k 1.0× 1.9k 1.0× 710 0.9× 273 0.4× 877 1.4× 221 5.8k
Thomas R. Rogers United Kingdom 42 2.6k 1.2× 3.5k 1.7× 197 0.2× 359 0.5× 1.1k 1.7× 173 5.8k
Jeffrey J. Tarrand United States 44 3.6k 1.7× 3.0k 1.5× 399 0.5× 415 0.6× 974 1.5× 135 6.6k
Ellen Jo Baron United States 32 2.0k 1.0× 1.7k 0.8× 250 0.3× 855 1.2× 526 0.8× 94 5.4k
Satoshi Ichiyama Japan 39 2.4k 1.1× 1.9k 0.9× 960 1.2× 665 0.9× 1.0k 1.6× 217 5.8k
Mitsuo Kaku Japan 40 2.0k 1.0× 1.8k 0.9× 445 0.5× 328 0.5× 1.3k 2.0× 333 5.7k
Craig Shapiro United States 14 696 0.3× 2.2k 1.1× 1.2k 1.4× 317 0.4× 598 0.9× 30 6.5k
Kwen‐Tay Luh Taiwan 48 2.0k 1.0× 1.8k 0.9× 612 0.8× 785 1.1× 1.3k 2.0× 149 6.0k
Emine Alp Türkiye 30 1.1k 0.5× 682 0.3× 234 0.3× 281 0.4× 323 0.5× 145 3.1k

Countries citing papers authored by Jason E. Stout

Since Specialization
Citations

This map shows the geographic impact of Jason E. Stout's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jason E. Stout with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jason E. Stout more than expected).

Fields of papers citing papers by Jason E. Stout

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jason E. Stout. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jason E. Stout. The network helps show where Jason E. Stout may publish in the future.

Co-authorship network of co-authors of Jason E. Stout

This figure shows the co-authorship network connecting the top 25 collaborators of Jason E. Stout. A scholar is included among the top collaborators of Jason E. Stout based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jason E. Stout. Jason E. Stout is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Luna, R. De, et al.. (2024). Presenting Characteristics, Treatment, and Visual Outcomes in Streptococcal Compared to Non-Streptococcal Endophthalmitis. Cureus. 16(8). e65974–e65974. 1 indexed citations
2.
Kram, Bridgette, et al.. (2024). Salvage treatment of Pneumocystis jirovecii pneumonia with micafungin and clindamycin: a case report. AME Medical Journal. 10. 7–7.
3.
Baker, Arthur W., Fan Jia, Jason E. Stout, et al.. (2024). Mycobacterium immunogenum acquisition from hospital tap water: a genomic and epidemiologic analysis. Journal of Clinical Microbiology. 62(6). e0014924–e0014924. 1 indexed citations
4.
Smith, Alison, Arthur W. Baker, Gary M. Cox, et al.. (2024). Beyond Infection: Mortality and End-of-Life Care Associated With Infectious Disease Consultation in an Academic Health System. Clinical Infectious Diseases. 79(4). 864–870. 1 indexed citations
5.
Mourad, Ahmad, Nwora Lance Okeke, Cameron R. Wolfe, et al.. (2023). Disparities in Mpox Vaccination Among Priority Populations During the 2022 Outbreak. Open Forum Infectious Diseases. 10(9). ofad434–ofad434. 9 indexed citations
6.
Mourad, Ahmad, Nwora Lance Okeke, Cameron R. Wolfe, et al.. (2023). Concurrent Sexually Transmitted Infection Testing Among Patients Tested for Mpox at a Tertiary Healthcare System. Open Forum Infectious Diseases. 10(8). ofad381–ofad381. 4 indexed citations
7.
Mourad, Ahmad, Nicholas Turner, Arthur W. Baker, et al.. (2020). Social Disadvantage, Politics, and Severe Acute Respiratory Syndrome Coronavirus 2 Trends: A County-level Analysis of United States Data. Clinical Infectious Diseases. 72(10). e604–e607. 9 indexed citations
8.
Seidelman, Jessica, Sarah S. Lewis, Sonali D. Advani, et al.. (2020). Universal masking is an effective strategy to flatten the severe acute respiratory coronavirus virus 2 (SARS-CoV-2) healthcare worker epidemiologic curve. Infection Control and Hospital Epidemiology. 41(12). 1466–1467. 52 indexed citations
9.
Mourad, Ahmad, Arthur W. Baker, & Jason E. Stout. (2020). Reduction in Expected Survival Associated With Nontuberculous Mycobacterial Pulmonary Disease. Clinical Infectious Diseases. 72(10). e552–e557. 26 indexed citations
10.
Stout, Jason E., Nicholas Turner, Robert Belknap, et al.. (2019). Optimizing the Design of Latent Tuberculosis Treatment Trials: Insights from Mathematical Modeling. American Journal of Respiratory and Critical Care Medicine. 201(5). 598–605. 2 indexed citations
12.
Dorman, Susan E., Radojka M. Savić, Stefan Goldberg, et al.. (2014). Daily Rifapentine for Treatment of Pulmonary Tuberculosis. A Randomized, Dose-Ranging Trial. American Journal of Respiratory and Critical Care Medicine. 191(3). 333–343. 76 indexed citations
13.
Norton, Brianna L., et al.. (2013). Barriers to Using Text Message Appointment Reminders in an HIV Clinic. Telemedicine Journal and e-Health. 20(1). 86–89. 32 indexed citations
14.
Person, Anna K., Michela Blain, Helen Jiang, Petra W. Rasmussen, & Jason E. Stout. (2011). Text Messaging for Enhancement of Testing and Treatment for Tuberculosis, Human Immunodeficiency Virus, and Syphilis: A Survey of Attitudes Toward Cellular Phones and Healthcare. Telemedicine Journal and e-Health. 17(3). 189–195. 50 indexed citations
15.
Goswami, Neela D., Kouros Owzar, Emily J. Hecker, et al.. (2011). Discriminating between latent and active tuberculosis with multiple biomarker responses. Tuberculosis. 91(3). 250–256. 116 indexed citations
16.
Holland, David P., Gillian D Sanders, Carol Hamilton, & Jason E. Stout. (2009). Costs and Cost-effectiveness of Four Treatment Regimens for Latent Tuberculosis Infection. American Journal of Respiratory and Critical Care Medicine. 179(11). 1055–1060. 80 indexed citations
17.
Gadkowski, Lara Beth, et al.. (2009). HIV-Specific Health Care Utilization and Mortality among Tuberculosis/HIV Coinfected Persons. AIDS Patient Care and STDs. 23(10). 845–851. 10 indexed citations
18.
Hickey, Anthony J., Dongmei Lu, Elizabeth Dodds Ashley, & Jason E. Stout. (2006). Inhaled Azithromycin Therapy. Journal of Aerosol Medicine. 19(1). 54–60. 34 indexed citations
19.
Stout, Jason E.. (2004). Therapeutic Drug Monitoring in Patients with Tuberculosis and Advanced Human Immunodeficiency Virus Infection. 1 indexed citations
20.
Stout, Jason E., et al.. (2003). Safety of 2 Months of Rifampin and Pyrazinamide for Treatment of Latent Tuberculosis. American Journal of Respiratory and Critical Care Medicine. 167(6). 824–827. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026